Role of Indoor Pollutants on House Dust Mite Allergic Asthma

Status Withdrawn

Clinical Trial Summary

It seems that the aldehydes and NO2, at the levels found indoor, could be the aggravating factors for an allergic response. However this effect has not been demonstrated. The investigators plan to study the effect of exposure to standard doses of these pollutants on the bronchial reactivity as measured by bronchial challenge tests with dust mite extract in volunteers asthmatic, allergic to house dust mite.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Masking: Double Blind (Subject, Investigator)

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01019291
Study type	Interventional
Source	University Hospital, Strasbourg, France
Contact
Status	Withdrawn
Phase	N/A

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03850626` - Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients
Completed	`NCT02911688` - Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled O3 Exposure	Phase 2
Active, not recruiting	`NCT01776177` - The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy	N/A
Completed	`NCT00485576` - Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma	Phase 2
Completed	`NCT00515775` - Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children	N/A
Completed	`NCT00736801` - Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma	N/A
Completed	`NCT04259164` - Anti-inflammatory Effects Glycopyrronium	Phase 3
Active, not recruiting	`NCT04619017` - Airway Immune Response to Allergens (Use Lay Language Here)	Phase 1
Completed	`NCT01699594` - Change in Airway Responsiveness After Allergen Exposure	N/A
Completed	`NCT01353755` - 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma	Phase 3
Completed	`NCT00999466` - The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen	Phase 2
Completed	`NCT00434434` - A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma	Phase 2
Completed	`NCT00492076` - Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma	Phase 4
Completed	`NCT00829179` - Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma	Phase 3
Completed	`NCT00490425` - Prevention of Asthma and Allergy by Probiotic Lactobacillus GG	Phase 4
Recruiting	`NCT04542902` - Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma	N/A
Recruiting	`NCT04109534` - Effect of a Dietary Fatty Acid Supplementation on Symptoms and Bronchial Inflammation in Patients With Asthma	N/A
Active, not recruiting	`NCT05186025` - Tyrosine Allergoid Paediatric and Adult Study
Withdrawn	`NCT03307278` - House Dust Mite Induced Inflammasome Activation on Corticosteroid Resistance	N/A
Enrolling by invitation	`NCT06151938` - Evaluate Measurement Instruments Relevance in Assessing Effectiveness of ACARIZAX® in House Dust Mite Allergic Rhinitis